Skip to main content
SpringerLink
Log in

Changes in the Treatment of Acute Psychosis in a German Public Hospital from 1998 to 2004

  • Original Paper
  • Published:
Psychiatric Quarterly Aims and scope Submit manuscript

Abstract

Introduction

The aim of our study was to investigate antipsychotic treatment strategies in acute schizophrenic episodes in a German university hospital.

Methods

Documented pharmacological procedures in the first six weeks of acute episodes of schizophrenia in the years 1998 (n = 108), 2001 (n = 92), and 2004 (n = 94) were analyzed. Inclusion criteria were: admission voluntary and involuntary as inpatient to our acute ward with a diagnosis of F20× according to ICD 10.

Results

Atypical antipsychotics (AAP) were significant more frequently used in the first week of treatment in 2001 and 2004 compared to the year 1998. Switching to AAP occurred significantly earlier in 2001 and 2004 (after 7,6 ± 7 days in 1998, 3,5 ± 5 days in 2001 and 2,3 ± 5 days in 2004; P < 0.002). In all three years prescription of high potent typical antipsychotics decreased during the first six weeks of treatment. Involuntary treatment (P < 0.001) and age (P = 0.001) were significantly correlated to initial prescription of AAP. Involuntary admitted patients received more often a combination of high-potent conventional high potent typical neuroleptics and AAP (48% vs. 24%, P = 0.007).

Conclusion

Second generation atypicals are used more frequently according to current guidelines and switching from conventional medications occurs earlier.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Csernansky JG, Mahmoud R, Brenner R: A comparison of risperidone, haloperidol for the prevention of relapse in patients with schizophrenia. New England Journal of Medicine 346:16–22, 2002.

    Article  PubMed  CAS  Google Scholar 

  2. Emsley RA, Raniwalla J, Bailey PJ, et al: A comparison of the effects of quetiapine (‘seroquel’) and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group. International Clinical Psychopharmacology 15:121–131, 2000.

    PubMed  CAS  Google Scholar 

  3. Gomez JC, Crawford AM: Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial. Journal of Clinical Psychiatry 62 (Suppl 2):6–11, 2001.

    PubMed  CAS  Google Scholar 

  4. Kasper S, Lerman MN, McQuade RD, et al: Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia. International Journal of Neuropsychopharmacology 6:325–337, 2003.

    Article  PubMed  CAS  Google Scholar 

  5. American Psychiatric Association. Practice Guidelines for the Treatment of Patients With Schizophrenia. 2006. Available at: www.psych.org/psych_pract/treatg/pg/SchizPG-Complete-Feb04.pdf.

  6. Gaebel W, Weinmann S, Sartorius N, et al: Schizophrenia practice guidelines: international survey and comparison. British Journal of Psychiatry 187:248–255, 2005.

    Article  PubMed  Google Scholar 

  7. De Hert M, van Eyck D, De Nayer A: Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring. International Clinical Psychopharmacology 21 (Suppl 2):S11–S15, 2006.

    Article  PubMed  Google Scholar 

  8. Grohmann R, Engel RR, Geissler KH, et al: Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study. Pharmacopsychiatry 37 (Suppl 1):S27–S38, 2004.

    PubMed  Google Scholar 

  9. Centorrino F, Goren JL, Hennen J, et al: Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. American Journal of Psychiatry 161:700–706, 2004.

    Article  PubMed  Google Scholar 

  10. Gaebel W, Riesbeck M, Janssen B, et al: Atypical and typical neuroleptics in acute schizophrenia and related delusional disorders. Drug choice, switching and outcome under naturalistic treatment conditions. European archives of psychiatry and clinical neuroscience 253:175–184, 2003.

    Article  PubMed  Google Scholar 

  11. Davids E, Bunk C, Specka M, et al: Psychotropic drug prescription in a psychiatric university hospital in Germany. Progress in neuro-psychopharmacology and bi ological psychiatry, 30 (6):1109–16, 2006.

    Article  Google Scholar 

  12. Ganguly R, Kotzan JA, Miller LS, et al: Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998–2000. Journal of Clinical Psychiatry 65:1377–1388, 2004.

    Article  PubMed  Google Scholar 

  13. Centorrino F, Fogarty KV, Sani G, et al: Antipsychotic drug use: McLean Hospital, 2002. Human Psychopharmacology 20:355–358, 2005.

    Article  PubMed  Google Scholar 

  14. Weinmann S, Janssen B, Gaebel W: Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes. Journal of Clinical Psychiatry 65:1099–1105, 2004.

    PubMed  Google Scholar 

  15. Covell NH, Jackson CT, Evans AC, et al: Antipsychotic prescribing practices in Connecticut’s public mental health system: rates of changing medications and prescribing styles. Schizophrenia Bulletin 28:17–29, 2002.

    PubMed  Google Scholar 

  16. Rittmannsberger H, Meise U, Schauflinger K, et al: Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics. Eur opean Psychiatry 14:33–40, 1999.

    Article  CAS  Google Scholar 

  17. Ananth J, Parameswaran S, Gunatilake S: Antipsychotic polypharmacy. Current Pharmaceutical design 10:2231–2238, 2004.

    Article  PubMed  CAS  Google Scholar 

  18. Schussler G, Muller-Oerlinghausen B: Polypharmacy in psychiatric practice. Comprehensive Psychiatry 25:566–574, 1984.

    Article  PubMed  CAS  Google Scholar 

  19. Antai-Otong D: The art of prescribing. Principles of switching novel antipsychotic medications. Perspectives in Psychiatric Care 41:45–47, 2005.

    Article  PubMed  Google Scholar 

  20. Casey DE, Carson WH, Saha AR, et al: Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study. Psychopharmacology (Berl) 166:391–399, 2003.

    CAS  Google Scholar 

  21. Weiden PJ, Simpson GM, Potkin SG, et al: Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia. Journal of Clinical Psychiatry 64:580–588, 2003.

    Article  PubMed  CAS  Google Scholar 

  22. Simpson GM, Glick ID, Weiden PJ, et al: Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. American Journal of Psychiatry 161:1837–1847, 2004.

    Article  PubMed  Google Scholar 

  23. Leslie DL, Rosenheck RA: From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications. American Journal of Psychiatry 159:1534–1540, 2002.

    Article  PubMed  Google Scholar 

  24. Rothbard AB, Kuno E, Foley K: Trends in the rate and type of antipsychotic medications prescribed to persons with schizophrenia. Schizophrenia Bulletin 29:531–540, 2003.

    PubMed  Google Scholar 

  25. Hugenholtz GW, Heerdink ER, Meijer WE, et al: Reasons for switching between antipsychotics in daily clinical practice. Pharmacopsychiatry 38:122–124, 2005.

    Article  PubMed  CAS  Google Scholar 

  26. Ereshefsky L: Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic. Journal of Clinical Psychiatry 60 (Suppl 10):20–30, 1999.

    PubMed  CAS  Google Scholar 

  27. Tulloch KJ, Zed PJ: Intramuscular olanzapine in the management of acute agitation. The Annals of Pharmacotherapy 38:2128–2135, 2004.

    Article  PubMed  CAS  Google Scholar 

  28. Battaglia J: Pharmacological management of acute agitation. Drugs 65:1207–1222, 2005.

    Article  PubMed  CAS  Google Scholar 

  29. Johns CA, Thompson JW: Adjunctive treatments in schizophrenia: pharmacotherapies and electroconvulsive therapy. Schizophrenia Bulletin 21:607–619, 1995.

    PubMed  CAS  Google Scholar 

  30. Voirol P, Robert PA, Meister P, et al: Psychotropic drug prescription in a psychiatric university hospital. Pharmacopsychiatry 32:29–37, 1999.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rhine Clinics Essen, Department of Psychiatry and Psychotherapy, University of Duisburg-Essen, Virchowstr. 174, Essen, 45147, Germany

    Tiemo Wessels M.D., Dandy Grünler M.D., Christa Bunk, Michael Specka Ph.D., Markus Gastpar M.D. & Eugen Davids M.D.

  2. Rhine Clinics Essen, Department of Addictive Behavior and Addiction Medicine, University of Duisburg-Essen, Virchowstr. 174, Essen, 45147, Germany

    Norbert Scherbaum M.D.

Authors
  1. Tiemo Wessels M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dandy Grünler M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christa Bunk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael Specka Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Markus Gastpar M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Norbert Scherbaum M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Eugen Davids M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tiemo Wessels M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wessels, T., Grünler, D., Bunk, C. et al. Changes in the Treatment of Acute Psychosis in a German Public Hospital from 1998 to 2004. Psychiatr Q 78, 91–99 (2007). https://doi.org/10.1007/s11126-006-9030-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11126-006-9030-y

Keywords

Search

Navigation